Search research articles
Contact Us
Filters
Showing results (201-210 of 237) with videos related to
Page
of 24
Sort By:
BMC Neuroscience
|
October 21, 2015
Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia
Jia Luo, Sue H Lee, Lawren VandeVrede, et al.
ACS Infectious Diseases
|
May 5, 2021
Probing the Surface of a Parasite Drug Target Thioredoxin Glutathione Reductase Using Small Molecule Fragments
Francesca Fata, Ilaria Silvestri, Matteo Ardini, et al.
Free Radical Biology & Medicine
|
December 25, 2019
Ectopic suicide inhibition of thioredoxin glutathione reductase
Ilaria Silvestri, Haining Lyu, Francesca Fata, et al.
Toxins
|
June 23, 2017
Deoxynivalenol Biomarkers in the Urine of UK Vegetarians
Liz Wells, Laura Hardie, Courtney Williams, et al.
Journal of Medicinal Chemistry
|
July 10, 2013
Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors
Isaac T Schiefer, Subhasish Tapadar, Vladislav Litosh, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 15, 2011
Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A)
L P Hemachandra, P Madhubhani, R Chandrasena, et al.
Oncogene
|
February 22, 2023
TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer
Rakesh Sathish Nair, Sandeep Kumar, Subhasis Das, et al.
Oncogene
|
September 13, 2021
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3
Sunil Kumar Singh, Sandeep Kumar, Navin Viswakarma, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligands
Megan S Laham, Martha Ackerman-Berrier, Fahmida Alam, et al.
Breast Cancer Research and Treatment
|
July 23, 2020
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
Arkadiusz Z Dudek, Li C Liu, James H Fischer, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 237) with videos related to
Sort By:
Page
of 24
BMC Neuroscience
|
October 21, 2015
Re-engineering a neuroprotective, clinical drug as a procognitive agent with high in vivo potency and with GABAA potentiating activity for use in dementia
Jia Luo, Sue H Lee, Lawren VandeVrede, et al.
ACS Infectious Diseases
|
May 5, 2021
Probing the Surface of a Parasite Drug Target Thioredoxin Glutathione Reductase Using Small Molecule Fragments
Francesca Fata, Ilaria Silvestri, Matteo Ardini, et al.
Free Radical Biology & Medicine
|
December 25, 2019
Ectopic suicide inhibition of thioredoxin glutathione reductase
Ilaria Silvestri, Haining Lyu, Francesca Fata, et al.
Toxins
|
June 23, 2017
Deoxynivalenol Biomarkers in the Urine of UK Vegetarians
Liz Wells, Laura Hardie, Courtney Williams, et al.
Journal of Medicinal Chemistry
|
July 10, 2013
Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors
Isaac T Schiefer, Subhasish Tapadar, Vladislav Litosh, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 15, 2011
Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A)
L P Hemachandra, P Madhubhani, R Chandrasena, et al.
Oncogene
|
February 22, 2023
TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer
Rakesh Sathish Nair, Sandeep Kumar, Subhasis Das, et al.
Oncogene
|
September 13, 2021
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3
Sunil Kumar Singh, Sandeep Kumar, Navin Viswakarma, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligands
Megan S Laham, Martha Ackerman-Berrier, Fahmida Alam, et al.
Breast Cancer Research and Treatment
|
July 23, 2020
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy
Arkadiusz Z Dudek, Li C Liu, James H Fischer, et al.
Page
of 24